tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Holding SYRE?
Track your performance easily

Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?

421 Followers

Spyre Therapeutics (SYRE) Ownership Overview

11.12%17.06%3.48%10.17%58.16%
11.12% Insiders
3.48% Other Institutional Investors
10.17% ETFs
58.16% Public Companies and
Individual Investors
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 30.72% of the company’s stock is owned by Institutional Investors, 11.12% is owned by Insiders, and 58.16% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 05, 2024
xxxxxxxxxxxxx
$522018

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$3408950
Jun 30, 2024
xxxxxxxxxxxxx
$6174102
Jun 30, 2024
xxxxxxxxxxxxx
$6888312
Jun 30, 2024
xxxxxxxxxxxxx
$15657660

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,830,177Insider9.39%190,067,465
4,018,101Institution7.81%158,112,274
3,031,018Institution5.89%119,270,558
2,402,889Institution4.67%94,553,682
1,640,468Institution3.19%64,552,416
1,586,386Institution3.08%62,424,289
1,380,682Institution2.68%54,329,837
1,362,940Institution2.65%53,631,689
959,468Institution1.87%37,755,066
910,295Institution1.77%35,820,108

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,640,468Institution3.19%64,552,416
1,586,386Institution3.08%62,424,289
1,362,940Institution2.65%53,631,689
959,468Institution1.87%37,755,066
910,295Institution1.77%35,820,108
439,387Institution0.85%17,289,878
368,752Institution0.72%14,510,391
288,785Institution0.56%11,363,690
273,800Institution0.53%10,774,030
207,880Institution0.40%8,180,078

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,471,407Institution2.86%43,274,080
947,888Institution1.84%37,299,393
793,404Institution1.54%31,398,963
633,802Institution1.23%18,640,117
304,077Institution0.59%11,965,430
204,546Institution0.40%8,094,908
123,015Institution0.24%4,840,640
158,346Institution0.31%4,656,956
84,672Institution0.16%2,490,204
50,852Institution0.10%2,001,026

FAQ

Who Owns Spyre Therapeutics (SYRE)?
According to the latest TipRanks data, approximately 3.48% of the company's stock is held by institutional investors, 11.12% is held by insiders, and 58.16% is held by retail investors.
    What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.48% of Spyre Therapeutics (SYRE) stock is held by institutional investors.
      What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.16% of Spyre Therapeutics (SYRE) stock is held by retail investors.
        Who owns the most shares of Spyre Therapeutics (SYRE)?
        Fairmount Funds Management LLC owns the most shares of Spyre Therapeutics (SYRE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis